Cannabidiol oxidation product HU-331 is a potential anticancer cannabinoid-quinone: a narrative review
Abstract Cannabidiol and related cannabinoids are under exploration for the treatment of a number of disease states. The cannabinoid-quinone HU-331 has been studied as a potential anticancer therapeutic. Previous studies provide evidence that HU-331 displays anticancer activity without some of the k...
Saved in:
Main Authors: | Judy Trac (Author), J. Myles Keck (Author), Joseph E. Deweese (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2021-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Interplay of Ascorbic Acid with Quinones-Chelators-Influence on Lipid Peroxidation: Insight into Anticancer Activity
by: Olga Yu. Selyutina, et al.
Published: (2022) -
Binding and Signaling Studies Disclose a Potential Allosteric Site for Cannabidiol in Cannabinoid CB2 Receptors
by: Eva Martínez-Pinilla, et al.
Published: (2017) -
Cure-All cannabidiol? The cannabidiol content of commercial products
by: Michaela Mouton, et al.
Published: (2024) -
Quinones as Neuroprotective Agents
by: Ángel Cores, et al.
Published: (2023) -
Anticancer activity of Nigella sativa (black seed) and its relationship with the thermal processing and quinone composition of the seed
by: Agbaria R, et al.
Published: (2015)